Source: Annual Congress 2013 –COPD drugs: new findings
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Trofimenko, B. Chernyak (Irkutsk, Russian Federation). Bronchial hyperresponsiveness as a predictor of treatment-response in COPD. Eur Respir J 2013; 42: Suppl. 57, 4154

Member's Comments

No comment yet.

Related content which might interest you: The pulmonary artery-aorta ratio, exacerbation rate and quality of life in stable COPD patients Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 Impact of lung function impairment and exacerbation history on COPD patient-reported utility Source: International Congress 2014 – COPD markers Year: 2014 Bronchial hyperresponsiveness in COPD: Impact on survival outcomes Source: International Congress 2017 – Primary care management of asthma and COPD Year: 2017 The association between objective CT measures of bronchiectasis and health-related quality of life in COPD Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 The influence of bronchial asthma as a comorbidity of COPD on the COPD assessment test (CAT) Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 Predictors of good inhaler technique in asthma and COPD Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Psychopathology in patients with bronchial asthma Source: Annual Congress 2013 –Asthma at the bedside Year: 2013 Bronchial thermoplasty in patients with very severe asthma: Safety and clinical outcomes Source: International Congress 2016 – Airway stenting and ablation Year: 2016 The effect of tiotropium bromide on lung function parameters in patients with asthma- COPD overlap syndrome Source: International Congress 2016 – Asthma points to ponder Year: 2016 Assessing COPD profiles and outcomes by dyspnoea severity Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Effects of ciclesonide on the management of stable COPD with airway eosinophilia Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Frequency of COPD exacerbations and severity of COPD Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Benefits of self-management education in COPD exacerbations Source: International Congress 2015 – Best abstracts in chronic care Year: 2015 Assessment of quality of life of bronchiectasis patients associated with asthma and COPD. Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases Year: 2019 Exacerbations in patients with chronic obstructive lung disease (COPD) and concomitant asthma Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 Do obese asthmatics have a worse bronchodilator response? Source: International Congress 2015 – Monitoring airway diseases with lung function tests Year: 2015 Influence of basic therapy of bronchial asthma (BA) on respiratory symptoms in patients with pulmonary TB associated with bronchial asthma Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014 Risk factors of bronchial hyperresponsiveness in COPD Source: International Congress 2015 – COPD: interesting notes Year: 2015 Does small-airways dysfunction predispose to greater perceived respiratory symptoms during bronchoconstriction in asthma? Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 Quality of life in asthmatics with osmotic airway hyperresponsiveness (AHR) Source: International Congress 2016 – Asthma points to ponder Year: 2016